SMTL ID : 7m0m.1

HPK1 IN COMPLEX WITH COMPOUND 1

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.93 Å

Oligo State

homo-dimer

Ligands

2 x YK1: 4-[2-fluoro-6-(trifluoromethyl)anilino]-2-[(6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)amino]pyrimidine-5-carboxamide(Non-covalent)

YK1.1: 18 residues within 4Å: Chain A: L.22, G.23, G.24, G.25, V.30, A.43, M.90, E.91, F.92, C.93, G.94, G.96, D.100, A.140, N.141, L.143, A.153, D.154 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:A.43, A:L.143 Hydrogen bonds: A:E.91, A:C.93, A:C.93, A:G.96 Water bridges: A:D.100 Salt bridges: A:D.100 YK1.2: 18 residues within 4Å: Chain B: L.22, G.23, G.24, G.25, V.30, A.43, V.74, M.90, E.91, F.92, C.93, G.94, G.96, D.100, N.141, L.143, A.153, D.154 10 PLIP interactions: 10 interactions with chain B Hydrophobic interactions: B:A.43, B:L.143 Hydrogen bonds: B:E.91, B:C.93, B:C.93, B:G.96 Water bridges: B:S.97, B:D.100, B:D.154 Salt bridges: B:D.100

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Vara, B.A. et al., Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds. Acs Med.Chem.Lett. (2021)

Release Date

2021-04-07

Peptides

Mitogen-activated protein kinase kinase kinase kinase 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Mitogen-activated protein kinase kinase kinase kinase 1